Cas:1009630-24-3 4-(4-chlorophenyl)-3-methyl-1-phenylindeno[2,1-e]pyrazolo[3,4-b]pyridine-5(1H)-one manufacturer & supplier

Chemical Name:4-(4-chlorophenyl)-3-methyl-1-phenylindeno[2,1-e]pyrazolo[3,4-b]pyridine-5(1H)-one

CAS.NO:1009630-24-3

Synonyms:4-(4-chlorophenyl)-3-methyl-1-phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-one;3-methyl-1-phenyl-4-(4-chlorophenyl)-5-oxoindeno[2′,1′:5,6]pyrido[2,3-d]pyrazole;3-methyl-1-phenyl-4-(4-chlorophenyl)indeno[2′,1′:5,6]pyrido[2,3-c]pyrazol-5-one;4-(4-Chlorophenyl)-3-methyl-1-phenyl-1H-indeno[1,2-b]pyrazolo[4,3-e]pyridin-5-one

Molecular Formula:C₂₆H₁₆ClN₃O

Molecular Weight:421.87800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:47.78000

Exact Mass:421.09800

LogP:6.26070

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(4-chlorophenyl)-3-methyl-1-phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-Chlorophenyl)-3-methyl-1-phenyl-1H-indeno[1,2-b]pyrazolo[4,3-e]pyridin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-methyl-1-phenyl-4-(4-chlorophenyl)indeno[2′,1′:5,6]pyrido[2,3-c]pyrazol-5-one Use and application,3-methyl-1-phenyl-4-(4-chlorophenyl)-5-oxoindeno[2′,1′:5,6]pyrido[2,3-d]pyrazole technical grade,usp/ep/jp grade.

Related News: Ireland is globally recognised as a hub for the Life Sciences sector and this news is a real vote of confidence in us and our capacity.” 5-tert-butyl-2-heptan-2-yl-4H-pyrazol-3-one manufacturers The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. ent-Naxagolide Hydrochloride suppliers GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. 4-(4-bromophenyl)-2H-triazole vendor & factory Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial.,GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix.